Loading...

DISRUPTING THE BIO-TERRORISM
DEFENSE INDUSTRY

The deliberate engineering and release of viruses, bacteria, toxins, or other harmful agents to cause illness or death is of increasing concern across the world. Preparedness for and response to an attack involving biological agents are complicated in nature and require a diverse set of countermeasures.

Our product suite of technologies target the following bio-terrorism industry segments:

PUBLIC HEALTH PREPAREDNESS

Reducing infectious disease and cross contamination risk within public sectors.

PATHOGEN COUNTERMEASURES

Providing pathogen risk reduction via adaptive & scalable disinfection solutions.

REMOTE DECONTAMINATION

Autonomous & mechatronic systems to replace risky human mediation.

BIOLOGICAL WASTE REMOVAL

Such as the Mortuary Industry, minimization of pathogen spread.

DEFINING THE PROBLEM

Governments around the world must remain vigilant in their efforts to counter all possible bioterrorism scenarios. A bioterrorism attack, “the deliberate release of viruses, bacteria, or other harmful germs that are determined to cause public health risk or death.” could cause lasting catastrophic damage to populations and economies.

While these germs may originally come from nature, the possibility exists to modify or reengineer these pathogens to increase their ability to spread among populations, cause diseases, and/or resist medical treatment.

THE NEED FOR BIO-TERRORISM COUNTERMEASURES & DEFENSE

Biological agents are known to be able to spread through either air, water, and/or in food. Others can spread through personal contact, making detection difficult.

Government and military preparedness for and response to an attack involving such a biological agent are complicated by the sheer number and similarity of many of these agents. Long incubation periods and consequent delayed onset of diseases as well as secondary transmission are all to be considered. Naturally occurring pathogens such as anthrax, ebola, plague, or smallpox (to name a few) used by bioterrorists may be genetically engineered to resist existing treatment and therapies and may evade vaccine-induced immunity.

MARKET GROWTH

+$19.9 BILLION

BIODEFENSE MARKET FORECAST- '20-'27

EMERGING DISEASES

+60 IDENTIFIED

EMERGING & RE-IMERGING INFECTIOUS DISEASES

YEARLY BURDEN

~15M DEATHS

Infectious Disease Deaths - Global

THE COVID-19 COST

+$16 TRILLION

EST. ECONOMIC COST OF COVID-19 CRISIS

Bioterrorism Defense & Harmful Bioagents Countermeasures - The Challenge

There are currently around 1,500 microbes identified to be a known source of disease among the human population. Infectious diseases have contributed to major challenges to human progress and survival along with wars and famine. Confronted with a constant background of new and established infections, epidemics (both new and old) are expected to periodically emerge – grossly impacting the global burden of infections.

Bioterrorism defense can never fully anticipate all eventualities, ranging from defense systems being inept at predicting the most likely scenario. Governing bodies may see higher prioritization for Missile Defense Shields against rogue states over random acts of calculated biological warfare from a hidden and insidious enemy. The challenge in proper preparedness and bio-terrorism defense is multi-faceted, and one such facet is in sterilization and disinfection technologies.

Global Death Burden Of Infectious Diseases

  • Respiratory Infections
  • HIV & AIDS
  • Other Infectious Diseases
  • Diarrhoeal Diseases
  • Tuberculosis
  • Vaccine Preventable Childhood Diseases
  • Malaria
  • STDS (Other than HIV)
  • Meningitis
  • Hepatitis B & C
  • Tropical Parasitic Diseases
  • Dengue Fever

The above listed figure does not include the additional millions of deaths occurring due to past infections (example: Streptococcal Rheumatic Heart Disease) or due to complications correlated with infections that are considered chronic – such as liver failure and hepatocellular carcinoma from persons infected with Hepatitis B or C.

The burden of morbidity (ill health) and mortality associated with infectious diseases falls most heavily on people in developing countries, and particularly on infants and children (about three million children die each year from malaria and diarrhoeal diseases alone). In developed nations, infectious disease mortality disproportionately affects indigenous and disadvantaged minorities. [NCBI] – Figures Published: W.H.O

THE AERIMOS SOLUTION

MINIMIZING INFECTIOUS RISK THROUGH
STERILIZATION & DISINFECTION

CONVENTIONAL SOLUTIONS FALL SHORT

Conventional disinfection technologies can only achieve 2-3 logs (99% – 99.9%) of reduction (kill) of pathogens and many fall short for both soft and hard surfaces. Decontamination in this range allows the regrowth of pathogens within as little as 12 hours.

INTRODUCING THE NEW GOLD STANDARD

The Aerimos Disinfectant sprayer prevents regrowth with its industry-disruptive 5 log+ (99.999%+) elimination of all viral & bacterial pathogens, all while leaving zero residue.

  • Eco-friendly, no residues, non-Corrosive, potent deodorizer.
  • Demonstrated efficacy for SARS-CoV-2, Anthrax, Ebola, etc.
  • 1000x faster acting & stronger than Chlorine Bleach.
  • Eliminate mould, mildew, mites, and spores.
  • Safe to handle, and affordable to operate.

AERIMOS DISINFECTION & STERILIZATION SPRAYER

PRODUCTS & TECHNOLOGY